Center and regional opportunity views
Where protocol-relevant signals concentrate, which populations and pathways they represent, and how data coverage affects the view.
02 / AFTER SITES ARE SELECTED / Patient Identification & Enrollment Intelligence
Where are the patient opportunities around the sites we already selected?
Apply protocol criteria to permitted clinical and real-world evidence around selected or active sites. We deliver both aggregate opportunity views and patient-level leads that authorized clinical teams can verify and act on.
What you receive
Patient-level leads for review
Candidate-level signals with the criteria supported, missing or conflicting information, and the checks required before a clinical team can determine eligibility.
An actionable review handoff
A prioritized review queue and supporting rationale for authorized teams. Data granularity, recipient access and refresh cadence are agreed for the engagement.
What you bring
- Current protocol and eligibility criteria
- Selected or active sites, catchment areas and current enrollment context
- Any data or access arrangements already available; you do not need to bring a complete patient database
You bring the trial context. We scope the evidence.
OncoLattice identifies the evidence needed and coordinates access through appropriately licensed, partner-supplied or sponsor-provided sources. Available coverage, procurement responsibility, cost and permitted uses are confirmed before work begins. Having a complete patient database is not a prerequisite for an initial discussion.
Agree the deliverables, data access, review responsibilities, timing, fees and acceptance criteria before work begins. This is a scoped service—not access to a self-serve patient database.
How the work moves forward
A patient lead is not a confirmed eligible or enrolled participant. Final eligibility, patient contact, consent and enrollment remain with authorized sites, PIs and clinical teams. Patient-level material is shared only through an agreed, permitted channel—not this website.
ONCOLOGY ENROLLMENT INTELLIGENCE
Where is your trial today?
Tell us whether you are choosing sites or working with sites already selected. Start with non-confidential context; we will define the relevant deliverable and access arrangements together.